N6,N6-dimethyladenosine for use in treating or preventing primary and metastatic breast cancer

The present invention relates to the field of biotechnology. The present invention relates to a compound of formula (I), namely N6,N6-dimethyladenosine, for use in the treatment or prevention of primary and metastatic breast cancer. The present invention also relates to a combination of a compound o...

Full description

Saved in:
Bibliographic Details
Main Authors KYTOEMAA, RIIKKA ANNIKA, TUOMELA, JOHANNA MIRJAMI, CASTELLS BOLIART, JOSEP, PASCUAL GILABERT, MARTA, MONTILLA AREVALO, RAFAEL, VUORIKOSKI, HEIKKI JOHANNES, SEPPAENEN, JANI ANTERO, HALLEEN, JUSSI MARKO JUHANI, LOPEZ GOMEZ, CRISTINA
Format Patent
LanguageEnglish
French
German
Published 26.03.2014
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the field of biotechnology. The present invention relates to a compound of formula (I), namely N6,N6-dimethyladenosine, for use in the treatment or prevention of primary and metastatic breast cancer. The present invention also relates to a combination of a compound of formula (I) with at least one further compound for use in the treatment or prevention of primary and metastatic breast cancer. The present invention further relates to a pharmaceutical composition comprising the compound of formula (I) or the combination.
Bibliography:Application Number: EP20120382365